LUXHT
Index Performance
Overview
Description
The coming years will welcome a new breed of historically important, publicly listed healthcare technology companies that more closely resemble the tech mega-caps of today, with platform-based innovation, highly scalable business models, network effects, high impact, and high value creation. Technologies such as teleoperated devices, wearable sensors, and machine learning and artificial intelligence are arming patients and healthcare providers with tools to make better and quicker clinical decisions. The intersection of healthcare and technology has the potential to transform everything from how patients interact with care providers, to how diagnostic data is obtained and analyzed, from the ways interventions are recommended to the ways outcomes are measured. Developed by Lux Capital, the Lux Health + Tech Index™ recognizes the life-changing power of healthcare + technology.
Full methodology- TickerLUXHT
- Inception Date04/27/2021
- WeightingCustom
- # of holdings44
What's inside?
Holdings
All holdings as of April 26, 2024
| Oscar Health, Inc. (OSCR) | 13.54% | $3.54B | 47.92% | N/A | 0.40 |
| Natera, Inc. (NTRA) | 5.67% | $11.20B | 31.99% | 45.52% | 6.25 |
| Align Technology, Inc. (ALGN) | 4.20% | $23.26B | 5.76% | 70.33% | 6.10 |
| GoodRx Holdings, Inc. (GDRX) | 4.07% | $670.58M | -2.12% | 77.33% | 3.72 |
| Hims & Hers Health, Inc. (HIMS) | 3.43% | $2.57B | 65.49% | 80.90% | 1.89 |
| EXACT Sciences Corp. (EXAS) | 3.24% | $10.82B | 19.93% | 70.14% | 6.05 |
| Lifestance Health Group, Inc. (LFST) | 3.05% | $2.37B | 22.82% | 21.00% | 3.13 |
| Inspire Medical Systems, Inc. (INSP) | 3.00% | $7.19B | 53.19% | 84.54% | 8.84 |
| Intuitive Surgical, Inc. (ISRG) | 2.71% | $133.13B | 11.46% | 65.87% | 19.01 |
| NeoGenomics, Inc. (NEO) | 2.71% | $1.81B | 16.07% | 35.40% | 3.76 |
| Axonics, Inc. (AXNX) | 2.69% | $3.40B | 33.86% | 72.46% | 7.47 |
| iRhythm Technologies, Inc. (IRTC) | 2.64% | $3.47B | 19.90% | 67.35% | 6.62 |
| Accolade, Inc. (ACCD) | 2.63% | $610.75M | 14.09% | 34.67% | 1.86 |
| Veeva Systems, Inc. (VEEV) | 2.62% | $32.47B | 9.68% | 70.73% | 12.67 |
| Hologic, Inc. (HOLX) | 2.54% | $17.83B | -5.69% | 54.70% | 4.49 |
| Schrödinger, Inc. (SDGR) | 2.51% | $1.52B | 19.73% | 64.66% | 10.82 |
| IQVIA Holdings, Inc. (IQV) | 2.47% | $42.75B | 3.77% | 27.35% | 3.73 |
| DexCom, Inc. (DXCM) | 2.39% | $49.45B | 24.21% | 61.01% | 15.12 |
| Progyny, Inc. (PGNY) | 2.17% | $3.09B | 38.34% | 21.94% | 3.12 |
| Myriad Genetics, Inc. (MYGN) | 2.11% | $1.63B | 11.03% | 62.96% | 2.12 |
| Definitive Healthcare Corp. (DH) | 1.83% | $823.35M | 12.92% | 65.60% | 5.64 |
| Fulgent Genetics, Inc. (FLGT) | 1.76% | $598.67M | -53.27% | 33.40% | 1.55 |
| Health Catalyst, Inc. (HCAT) | 1.66% | $353.13M | 7.13% | 31.29% | 1.53 |
| Veracyte, Inc. (VCYT) | 1.65% | $1.45B | 21.76% | 61.81% | 4.97 |
| Clover Health Investments Corp. (CLOV) | 1.64% | $275.84M | -41.81% | N/A | 0.23 |
| ResMed, Inc. (RMD) | 1.53% | $32.07B | 7.17% | 56.94% | 6.57 |
| Guardant Health, Inc. (GH) | 1.51% | $2.11B | 25.45% | 59.74% | 5.70 |
| Teladoc Health, Inc. (TDOC) | 1.51% | $2.20B | 2.68% | 54.74% | 1.15 |
| Tandem Diabetes Care, Inc. (TNDM) | 1.48% | $2.28B | -6.68% | 47.33% | 2.50 |
| PROCEPT BioRobotics Corp. (PRCT) | 1.46% | $2.66B | 81.55% | 52.17% | 13.23 |
| Masimo Corp. (MASI) | 1.40% | $7.20B | 0.60% | 49.00% | 3.49 |
| 10X Genomics, Inc. (TXG) | 1.22% | $2.91B | 19.81% | 66.15% | 10.12 |
| Castle Biosciences, Inc. (CSTL) | 1.20% | $558.33M | 60.38% | 74.72% | 1.60 |
| Globus Medical, Inc. (GMED) | 1.18% | $5.71B | 53.34% | 61.80% | 3.90 |
| Illumina, Inc. (ILMN) | 1.12% | $19.43B | -1.75% | 61.06% | 5.15 |
| Twist Bioscience Corp. (TWST) | 1.08% | $1.82B | 31.81% | 40.51% | 7.24 |
| Doximity, Inc. (DOCS) | 1.05% | $2.91B | 17.37% | 90.99% | 10.52 |
| Olink Holding AB (OLK) | 1.05% | $2.84B | 21.60% | 58.19% | 17.80 |
| Insulet Corp. (PODD) | 0.94% | $11.64B | 30.02% | 68.84% | 9.85 |
| CareDx, Inc. (CDNA) | 0.91% | $391.45M | -12.89% | 62.74% | 1.58 |
| Cytek Biosciences, Inc. (CTKB) | 0.74% | $753.55M | 17.67% | 56.69% | 5.20 |
| Adaptive Biotechnologies Corp. (ADPT) | 0.66% | $377.24M | -8.11% | 42.57% | 3.47 |
| Nevro Corp. (NVRO) | 0.62% | $412.02M | 4.63% | 65.51% | 1.58 |
| Pacific Biosciences of California, Inc. (PACB) | 0.38% | $400.25M | -0.26% | N/A | N/A |
